Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.92 |
| ▸ | NQO2 | P16083 | 6/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.59 |
| ▸ | HPGD | P15428 | 4/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.59 |
| ▸ | GLA | P06280 | 3/20 | 0.59 |
| ▸ | GAA | P10253 | 3/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.59 |
| ▸ | ACHE | P22303 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | POLB | P06746 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | NPC1 | O15118 | 2/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.58 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 4/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenazine SCHEMBL22345160 | 1.00 | MAPT (0.92) | MAPTNQO2ALDH1A1HPGDKDM4E | |
| Phenazine SCHEMBL9049 | 0.96 | MAPT (1.00) | MAPTNQO2ALDH1A1HPGDKDM4E | |
| Phenazine SCHEMBL27643128 | 0.96 | MAPT (1.00) | MAPTNQO2ALDH1A1HPGDKDM4E | |
| Phenazine SCHEMBL29356959 | 0.96 | MAPT (1.00) | MAPTNQO2ALDH1A1HPGDKDM4E | |
| Phenazine SCHEMBL3119916 | 0.92 | MAPT (0.92) | MAPTNQO2ALDH1A1HPGDKDM4E | |
| Phenazine SCHEMBL20475337 | 0.92 | MAPT (0.92) | MAPTNQO2ALDH1A1HPGDKDM4E | |
| Phenazine SCHEMBL11126178 | 0.92 | MAPT (0.92) | MAPTNQO2ALDH1A1HPGDKDM4E | |
| Phenazine SCHEMBL20475326 | 0.92 | MAPT (0.92) | MAPTNQO2ALDH1A1HPGDKDM4E | |
| Phenazine SCHEMBL6329249 | 0.92 | MAPT (0.92) | MAPTNQO2ALDH1A1HPGDKDM4E | |
| Phenazine SCHEMBL10866237 | 0.92 | MAPT (0.92) | MAPTNQO2ALDH1A1HPGDKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3594207-B1 | ELECTROCHEMICAL ENERGY STORAGE DEVICES | GENTEX CORP (US) | 2021-06-30 | — | — | EP | disclosed |
| US-10971718-B2 | Electrochemical energy storage devices | GENTEX CORPORATION (US) | 2021-04-06 | — | — | US | disclosed |
| EP-3131882-B1 | PHENAZINIUM MEDIATORS | ROCHE DIAGNOSTICS GMBH (DE) | 2020-07-15 | — | — | EP | disclosed |
| US-20200050070-A1 | ELECTROCHEMICAL ENERGY STORAGE DEVICES | GENTEX CORPORATION | 2020-02-13 | — | — | US | disclosed |
| US-10481456-B2 | Electrochemical energy storage devices | GENTEX CORPORATION (US) | 2019-11-19 | — | — | US | disclosed |
| EP-3164390-B1 | ELECTROCHROMIC DEVICES AND COMPOUNDS THEREFOR | GENTEX CORP (US) | 2019-09-18 | — | — | EP | disclosed |
| US-20180157139-A1 | ELECTROCHEMICAL ENERGY STORAGE DEVICES | GENTEX CORPORATION | 2018-06-07 | — | — | US | disclosed |
| US-9988358-B2 | Phenazinium mediators | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2018-06-05 | — | — | US | disclosed |
| US-9964828-B2 | Electrochemical energy storage devices | GENTEX CORPORATION (US) | 2018-05-08 | — | — | US | disclosed |
| US-20170226068-A1 | PHENAZINIUM MEDIATORS | ROCHE DIAGNOSTICS GMBH (DE) | 2017-08-10 | — | — | US | disclosed |
| EP-3164390-A1 | ELECTROCHEMICAL ENERGY STORAGE DEVICES | Gentex Corporation (US) | 2017-05-10 | — | — | EP | disclosed |
| EP-3131882-A1 | PHENAZINIUM MEDIATORS | Roche Diagnostics GmbH (DE) | 2017-02-22 | — | — | EP | disclosed |
| WO-2015183821-A1 | ELECTROCHEMICAL ENERGY STORAGE DEVICES | GENTEX CORPORATION (US) | 2015-12-03 | — | — | WO | disclosed |
| US-20150346573-A1 | ELECTROCHEMICAL ENERGY STORAGE DEVICES | GENTEX CORPORATION | 2015-12-03 | — | — | US | disclosed |
| WO-2015158645-A1 | PHENAZINIUM MEDIATORS | ROCHE DIAGNOSTICS GMBH (DE) | 2015-10-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10971718-B2 | Electrochemical energy storage devices | PC, PANK2, MCU | MAPT 2118/4885NQO2 1109/4885ALDH1A1 554/4885 |
| US-20170226068-A1 | PHENAZINIUM MEDIATORS | IL5, TRPV5, TRPM5 | MAPT 577/4885NQO2 455/4885ALDH1A1 1586/4885 |
| US-10481456-B2 | Electrochemical energy storage devices | PC, PANK2, VDAC2 | MAPT 2068/4885NQO2 816/4885ALDH1A1 650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.